Adipose proteome analysis: focus on mediators of insulin resistance

References

• Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the united states, 1999–2004. JAMA295(13), 1549–1555 (2006).
   PubMed Web of Science ®Google Scholar
• Shaw J. Epidemiology of childhood type 2 diabetes and obesity. Pediatr. Diabetes8(Suppl.) 97–115 (2007).
   Google Scholar
• Shimomura I, Hammer RE, Richardson JA et al. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev.12(20), 3182–3194 (1998).
   PubMed Web of Science ®Google Scholar
• Moitra J, Mason MM, Olive M et al. Life without white fat: a transgenic mouse. Genes Dev.12(20), 3168–3181 (1998).
   PubMed Web of Science ®Google Scholar
• Seip M, Trygstad O. Generalized lipodystrophy, congenital and acquired (lipoatrophy). Acta Paediatr. Suppl.413, 2–28 (1996).
   PubMedGoogle Scholar
• Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ. Res.96(9), 939–949 (2005).
   PubMed Web of Science ®Google Scholar
• Savage DB, Petersen KF, Shulman GI. Mechanisms of insulin resistance in humans and possible links with inflammation. Hypertension45(5), 828–833 (2005).
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS. Inflammation and metabolic disorders. Nature444(7121), 860–867 (2006).
   PubMed Web of Science ®Google Scholar
• Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology132(6), 2169–2180 (2007).
   PubMed Web of Science ®Google Scholar
• Savage DB, Petersen KF, Shulman GI. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol. Rev.87(2), 507–520 (2007).
   PubMed Web of Science ®Google Scholar
• Delarue J, Magnan C. Free fatty acids and insulin resistance. Curr. Opin. Clin. Nutr. Metab. Care10(2), 142–148 (2007).
   PubMed Web of Science ®Google Scholar
• Giorgino F, Laviola L, Eriksson JW. Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies. Acta Physiol. Scand.183(1), 13–30 (2005).
   PubMedGoogle Scholar
• Gesta S, Bluher M, Yamamoto Y et al. Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc. Natl Acad. Sci. USA103(17), 6676–6681 (2006).
   PubMed Web of Science ®Google Scholar
• Rosen ED, MacDougald OA. Adipocyte differentiation from the inside out. Nat. Rev. Mol. Cell. Biol.7(12), 885–896 (2006).
   PubMed Web of Science ®Google Scholar
• Tran TT, Yamamoto Y, Gesta S, Kahn CR. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab.7(5), 410–420 (2008).
   PubMed Web of Science ®Google Scholar
• Kim S, Huang LW, Snow KJ et al. A mouse model of conditional lipodystrophy. Proc. Natl Acad. Sci. USA104(42), 16627–16632 (2007).
   PubMed Web of Science ®Google Scholar
• Anand A, Chada K. In vivo modulation of Hmgic reduces obesity. Nat. Genet.24(4), 377–380 (2000).
   PubMed Web of Science ®Google Scholar
• Danforth E Jr. Failure of adipocyte differentiation causes Type II diabetes mellitus? Nat. Genet.26(1), 13 (2000).
   PubMed Web of Science ®Google Scholar
• Garg A, Misra A. Lipodystrophies: rare disorders causing metabolic syndrome. Endocrinol. Metab. Clin. North Am.33(2), 305–331 (2004).
   PubMed Web of Science ®Google Scholar
• Leow MK, Addy CL, Mantzoros CS. Clinical review 159: human immunodeficiency virus/highly active antiretroviral therapy-associated metabolic syndrome: clinical presentation, pathophysiology and therapeutic strategies. J. Clin. Endocrinol. Metab.88(5), 1961–1976 (2003).
   PubMedGoogle Scholar
• Wang MY, Grayburn P, Chen S, Ravazzola M, Orci L, Unger RH. Adipogenic capacity and the susceptibility to Type 2 diabetes and metabolic syndrome. Proc. Natl Acad. Sci. USA105(16), 6139–6144 (2008).
   PubMedGoogle Scholar
• Kim JY, van de Wall E, Laplante M et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J. Clin. Invest.117(9), 2621–2637 (2007).
   PubMed Web of Science ®Google Scholar
• Hammarstedt A, Andersson CX, Rotter Sopasakis V, Smith U. The effect of PPARγ ligands on the adipose tissue in insulin resistance. Prostaglandins Leukot. Essent. Fatty Acids73(1), 65–75 (2005).
   PubMed Web of Science ®Google Scholar
• Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature372(6505), 425–432 (1994).
   PubMed Web of Science ®Google Scholar
• Zhang J, Wu Y, Zhang Y, Leroith D, Bernlohr DA, Chen X. The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages. Mol. Endocrinol.22(6), 1416–1426 (2008).
   PubMedGoogle Scholar
• Wang ZV, Scherer PE. Adiponectin, cardiovascular function and hypertension. Hypertension51(1), 8–14 (2008).
   PubMed Web of Science ®Google Scholar
• Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol.6(10), 772–783 (2006).
   PubMed Web of Science ®Google Scholar
• Maeda N, Shimomura I, Kishida K et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med.8(7), 731–737 (2002).
   PubMed Web of Science ®Google Scholar
• Minokoshi Y, Kim YB, Peroni OD et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature415(6869), 339–343 (2002).
   PubMed Web of Science ®Google Scholar
• Steinberg GR, Rush JW, Dyck DJ. AMPK expression and phosphorylation are increased in rodent muscle after chronic leptin treatment. Am. J. Physiol. Endocrinol. Metab.284(3), E648–E654 (2003).
   Google Scholar
• Yamauchi T, Kamon J, Minokoshi Y et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med.8(11), 1288–1295 (2002).
   PubMed Web of Science ®Google Scholar
• Tomas E, Tsao TS, Saha AK et al. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc. Natl Acad. Sci. USA99(25), 16309–16313 (2002).
   PubMed Web of Science ®Google Scholar
• Chen MB, McAinch AJ, Macaulay SL et al. Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics. J. Clin. Endocrinol. Metab.90(6), 3665–3672 (2005).
   PubMed Web of Science ®Google Scholar
• Nawrocki AR, Rajala MW, Tomas E et al. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J. Biol. Chem.281(5), 2654–2660 (2006).
   PubMed Web of Science ®Google Scholar
• Iwaki M, Matsuda M, Maeda N et al. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes52(7), 1655–1663 (2003).
   PubMed Web of Science ®Google Scholar
• Steppan CM, Bailey ST, Bhat S et al. The hormone resistin links obesity to diabetes. Nature409(6818), 307–312 (2001).
   PubMed Web of Science ®Google Scholar
• Banerjee RR, Rangwala SM, Shapiro JS et al. Regulation of fasted blood glucose by resistin. Science303(5661), 1195–1198 (2004).
   PubMed Web of Science ®Google Scholar
• Steppan CM, Lazar MA. The current biology of resistin. J. Intern. Med.255(4), 439–447 (2004).
   PubMed Web of Science ®Google Scholar
• Yang Q, Graham TE, Mody N et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and Type 2 diabetes. Nature436(7049), 356–362 (2005).
   PubMed Web of Science ®Google Scholar
• Chen X, Cushman SW, Pannell LK, Hess S. Quantitative proteomic analysis of the secretory proteins from rat adipose cells using a 2D liquid chromatography-MS/MS approach. J. Proteome Res.4(2), 570–577 (2005).
   PubMed Web of Science ®Google Scholar
• Takebayashi K, Suetsugu M, Wakabayashi S, Aso Y, Inukai T. Retinol binding protein-4 levels and clinical features of type 2 diabetes patients. J. Clin. Endocrinol. Metab.92(7), 2712–2719 (2007).
   PubMed Web of Science ®Google Scholar
• Gavi S, Stuart LM, Kelly P et al. Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without Type 2 diabetes. J. Clin. Endocrinol. Metab.92(5), 1886–1890 (2007).
   PubMed Web of Science ®Google Scholar
• Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest.112(12), 1796–1808 (2003).
   PubMed Web of Science ®Google Scholar
• Xu H, Barnes GT, Yang Q et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest.112(12), 1821–1830 (2003).
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science259(5091), 87–91 (1993).
   PubMed Web of Science ®Google Scholar
• Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J. Clin. Endocrinol. Metab.83(3), 847–850 (1998).
   PubMed Web of Science ®Google Scholar
• Sartipy P, Loskutoff DJ. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc. Natl Acad. Sci. USA100(12), 7265–7270 (2003).
   PubMed Web of Science ®Google Scholar
• Marette A. Molecular mechanisms of inflammation in obesity-linked insulin resistance. Int. J. Obes. Relat. Metab. Disord.27(Suppl. 3) S46–S48 (2003).
   Google Scholar
• Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A. Tumor necrosis factor-α suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J. Biol. Chem.268(35), 26055–26058 (1993).
   PubMed Web of Science ®Google Scholar
• Aguirre V, Uchida T, Yenush L, Davis R, White MF. The c-jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of ser(307). J. Biol. Chem.275(12), 9047–9054 (2000).
   PubMed Web of Science ®Google Scholar
• Aguirre V, Werner ED, Giraud J, Lee YH, Shoelson SE, White MF. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J. Biol. Chem.277(2), 1531–1537 (2002).
   PubMed Web of Science ®Google Scholar
• Stephens JM, Pekala PH. Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-α. J. Biol. Chem.266(32), 21839–21845 (1991).
   PubMed Web of Science ®Google Scholar
• Steinberg GR, Michell BJ, van Denderen BJ et al. Tumor necrosis factor α-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metab.4(6), 465–474 (2006).
   PubMed Web of Science ®Google Scholar
• Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest.116(11), 3015–3025 (2006).
   PubMed Web of Science ®Google Scholar
• Gao Z, Zhang X, Zuberi A et al. Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes. Mol. Endocrinol.18(8), 2024–2034 (2004).
   PubMedGoogle Scholar
• Makowski L, Boord JB, Maeda K et al. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat. Med.7(6), 699–705 (2001).
   PubMed Web of Science ®Google Scholar
• Furuhashi M, Hotamisligil GS. Fatty acid-binding proteins: Role in metabolic diseases and potential as drug targets. Nat. Rev. Drug Discov.7(6), 489–503 (2008).
   PubMed Web of Science ®Google Scholar
• Hertzel AV, Smith LA, Berg AH et al. Lipid metabolism and adipokine levels in fatty acid-binding protein null and transgenic mice. Am. J. Physiol. Endocrinol. Metab.290(5), E814–E823 (2006).
   PubMed Web of Science ®Google Scholar
• Adachi J, Kumar C, Zhang Y, Mann M. In-depth analysis of the adipocyte proteome by mass spectrometry and bioinformatics. Mol. Cell. Proteomics6(7), 1257–1273 (2007).
   PubMed Web of Science ®Google Scholar
• Grimsrud PA, Picklo MJ S, Griffin TJ, Bernlohr DA. Carbonylation of adipose proteins in obesity and insulin resistance: Identification of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal. Mol. Cell. Proteomics6(4), 624–637 (2007).
   PubMed Web of Science ®Google Scholar
• Washburn MP, Wolters D, Yates JR 3rd. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol.19(3), 242–247 (2001).
   PubMed Web of Science ®Google Scholar
• Hu Q, Noll RJ, Li H et al. The orbitrap: a new mass spectrometer. J. Mass Spectrom.40(4), 430–443 (2005).
   PubMed Web of Science ®Google Scholar
• Chen CH. Review of a current role of mass spectrometry for proteome research. Anal. Chim. Acta624(1), 16–36 (2008).
   PubMed Web of Science ®Google Scholar
• Umar A, Jaremko M, Burgers PC, Luider TM, Foekens JA, Pasa-Tolic L. High-throughput proteomics of breast carcinoma cells: A focus on FTICR-MS. Expert Rev. Proteomics5(3), 445–455 (2008).
   PubMed Web of Science ®Google Scholar
• Zhou M, Veenstra T. Mass spectrometry: M/z 1983–2008. Biotechniques44(5), 667–668, 670 (2008).
   PubMedGoogle Scholar
• Domon B, Aebersold R. Mass spectrometry and protein analysis. Science312(5771), 212–217 (2006).
   PubMed Web of Science ®Google Scholar
• Cox J, Mann M. Is proteomics the new genomics? Cell130(3), 395–398 (2007).
   PubMed Web of Science ®Google Scholar
• Cravatt BF, Simon GM, Yates JR 3rd. The biological impact of mass-spectrometry-based proteomics. Nature450(7172), 991–1000 (2007).
   PubMed Web of Science ®Google Scholar
• Yates JR 3rd. Mass spectral analysis in proteomics. Annu. Rev. Biophys. Biomol. Struct.33297–33316 (2004).
   Google Scholar
• Miyagi M, Rao KC. Proteolytic 18O-labeling strategies for quantitative proteomics. Mass Spectrom. Rev.26(1), 121–136 (2007).
   PubMed Web of Science ®Google Scholar
• Stewart II, Thomson T, Figeys D. 18O labeling: a tool for proteomics. Rapid Commun. Mass Spectrom.15(24), 2456–2465 (2001).
   PubMed Web of Science ®Google Scholar
• Yao X, Freas A, Ramirez J, Demirev PA, Fenselau C. Proteolytic 18O labeling for comparative proteomics: model studies with two serotypes of adenovirus. Anal. Chem.73(13), 2836–2842 (2001).
   PubMed Web of Science ®Google Scholar
• Sidhu RS. Two-dimensional electrophoretic analyses of proteins synthesized during differentiation of 3T3-L1 preadipocytes. J. Biol. Chem.254(21), 11111–11118 (1979).
   PubMedGoogle Scholar
• Spiegelman BM, Frank M, Green H. Molecular cloning of mRNA from 3T3 adipocytes. Regulation of mRNA content for glycerophosphate dehydrogenase and other differentiation-dependent proteins during adipocyte development. J. Biol. Chem.258(16), 10083–10089 (1983).
   PubMed Web of Science ®Google Scholar
• Kratchmarova I, Kalume DE, Blagoev B et al. A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes. Mol. Cell. Proteomics1(3), 213–222 (2002).
   PubMed Web of Science ®Google Scholar
• Wang P, Mariman E, Keijer J et al. Profiling of the secreted proteins during 3T3-L1 adipocyte differentiation leads to the identification of novel adipokines. Cell. Mol. Life Sci.61(18), 2405–2417 (2004).
   PubMedGoogle Scholar
• Hess S, Chen X. Applications of proteomics to the study of adipose tissue. Methods Mol. Biol.456131–456140 (2008).
   Google Scholar
• Arner P. Resistin: yet another adipokine tells us that men are not mice. Diabetologia48(11), 2203–2205 (2005).
   PubMed Web of Science ®Google Scholar
• Alvarez-Llamas G, Szalowska E, de Vries MP et al. Characterization of the human visceral adipose tissue secretome. Mol. Cell. Proteomics6(4), 589–600 (2007).
   PubMed Web of Science ®Google Scholar
• Lim JM, Sherling D, Teo CF, Hausman DB, Lin D, Wells L. Defining the regulated secreted proteome of rodent adipocytes upon the induction of insulin resistance. J. Proteome Res.7(3), 1251–1263 (2008).
   PubMed Web of Science ®Google Scholar
• Zvonic S, Lefevre M, Kilroy G et al. Secretome of primary cultures of human adipose-derived stem cells: modulation of serpins by adipogenesis. Mol. Cell. Proteomics6(1), 18–28 (2007).
   PubMed Web of Science ®Google Scholar
• Celis JE, Moreira JM, Cabezon T et al. Identification of extracellular and intracellular signaling components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients: toward dissecting the molecular circuitry of epithelial-adipocyte stromal cell interactions. Mol. Cell. Proteomics4(4), 492–522 (2005).
   PubMed Web of Science ®Google Scholar
• Flower DR. The lipocalin protein family: structure and function. Biochem. J.318(Pt 1), 1–14 (1996).
   PubMed Web of Science ®Google Scholar
• Kjeldsen L, Bainton DF, Sengelov H, Borregaard N. Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood83(3), 799–807 (1994).
   PubMed Web of Science ®Google Scholar
• Flo TH, Smith KD, Sato S et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature432(7019), 917–921 (2004).
   PubMed Web of Science ®Google Scholar
• Berger T, Togawa A, Duncan GS et al. Lipocalin 2-deficient mice exhibit increased sensitivity to escherichia coli infection but not to ischemia–reperfusion injury. Proc. Natl Acad. Sci. USA103(6), 1834–1839 (2006).
   PubMed Web of Science ®Google Scholar
• Shen F, Hu Z, Goswami J, Gaffen SL. Identification of common transcriptional regulatory elements in interleukin-17 target genes. J. Biol. Chem.281(34), 24138–24148 (2006).
   PubMed Web of Science ®Google Scholar
• Garay-Rojas E, Harper M, Hraba-Renevey S, Kress M. An apparent autocrine mechanism amplifies the dexamethasone- and retinoic acid-induced expression of mouse lipocalin-encoding gene 24p3. Gene170(2), 173–180 (1996).
   PubMed Web of Science ®Google Scholar
• Yan QW, Yang Q, Mody N et al. The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes (2007).
   Google Scholar
• Wang Y, Lam KS, Kraegen EW et al. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance and hyperglycemia in humans. Clin. Chem.53(1), 34–41 (2007).
   PubMed Web of Science ®Google Scholar
• Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol. Rev.75(3), 473–486 (1995).
   PubMed Web of Science ®Google Scholar
• Goldstein BJ. Insulin resistance as the core defect in Type 2 diabetes mellitus. Am. J. Cardiol.90(5A), 3G–10G (2002).
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wolf-Yadlin A, Ross PL et al. Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules. Mol. Cell. Proteomics4(9), 1240–1250 (2005).
   PubMed Web of Science ®Google Scholar
• Ross PL, Huang YN, Marchese JN et al. Multiplexed protein quantitation in saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics3(12), 1154–1169 (2004).
   PubMed Web of Science ®Google Scholar
• Schmelzle K, Kane S, Gridley S, Lienhard GE, White FM. Temporal dynamics of tyrosine phosphorylation in insulin signaling. Diabetes55(8), 2171–2179 (2006).
   PubMed Web of Science ®Google Scholar
• Ong SE, Blagoev B, Kratchmarova I et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics1(5), 376–386 (2002).
   PubMed Web of Science ®Google Scholar
• Ibarrola N, Kalume DE, Gronborg M, Iwahori A, Pandey A. A proteomic approach for quantitation of phosphorylation using stable isotope labeling in cell culture. Anal. Chem.75(22), 6043–6049 (2003).
   PubMed Web of Science ®Google Scholar
• Bose R, Molina H, Patterson AS et al. Phosphoproteomic analysis of Her2/neu signaling and inhibition. Proc. Natl Acad. Sci. USA103(26), 9773–9778 (2006).
   PubMed Web of Science ®Google Scholar
• Park KS, Mohapatra DP, Misonou H, Trimmer JS. Graded regulation of the Kv2.1 potassium channel by variable phosphorylation. Science313(5789), 976–979 (2006).
   PubMed Web of Science ®Google Scholar
• Zhang G, Spellman DS, Skolnik EY, Neubert TA. Quantitative phosphotyrosine proteomics of EphB2 signaling by stable isotope labeling with amino acids in cell culture (SILAC). J. Proteome Res.5(3), 581–588 (2006).
   PubMed Web of Science ®Google Scholar
• Kruger M, Kratchmarova I, Blagoev B, Tseng YH, Kahn CR, Mann M. Dissection of the insulin signaling pathway via quantitative phosphoproteomics. Proc. Natl Acad. Sci. USA105(7), 2451–2456 (2008).
   PubMedGoogle Scholar
• Schulze WX, Mann M. A novel proteomic screen for peptide–protein interactions. J. Biol. Chem.279(11), 10756–10764 (2004).
   PubMedGoogle Scholar
• Sharma R, Yang Y, Sharma A, Awasthi S, Awasthi YC. Antioxidant role of glutathione S-transferases: protection against oxidant toxicity and regulation of stress-mediated apoptosis. Antioxid. Redox Signal.6(2), 289–300 (2004).
   PubMed Web of Science ®Google Scholar